Home / Latin America and the Caribbean / SUR

Suriname

Suriname appears only through international and donor bodies that compile figures across many countries, and no figures for the country are read directly from a national publisher. PEPFAR's results for the country are broken down by province and count only the sites PEPFAR supports. The assessment of national sources, country by country, is set out on the Methods page.

8,100

People living with HIV, 2025

WHO Global Health Observatory

50.0%

On antiretroviral treatment, 2025

WHO Global Health Observatory

$6k

United States HIV disbursements, 2012

OECD Creditor Reporting System

$815k

External HIV financing, all donors, 2024

OECD Creditor Reporting System

External HIV financing

OECD CRS · ForeignAssistance.gov

All donors
United States, OECD record
The Global Fund
United States, self-reported

Year	All donors	United States, OECD record	The Global Fund	United States, self-reported
2002	$39k	—	—	—
2003	$59k	—	—	—
2005	$1.2m	—	$1.1m	—
2006	$1.0m	—	$991k	—
2007	$2.4m	$62k	$2.3m	$62k
2008	$640k	—	$640k	—
2009	$2.1m	—	$2.0m	—
2010	$866k	$10k	$839k	$10k
2011	$1.1m	$132k	$870k	$119k
2012	$164k	$6k	$143k	$18k
2013	$405k	—	$386k	—
2014	$9k	—	—	—
2015	$1.2m	—	$1.2m	—
2016	$19k	—	—	—
2017	$40k	—	—	—
2018	$23k	—	—	—
2019	$3k	—	—	—
2020	$425k	—	$419k	—
2021	$724k	—	$724k	—
2022	$696k	—	$696k	—
2023	$409k	—	$409k	—
2024	$815k	—	$815k	—

22 rows, as drawn above. Values are rounded for display, and the download gives the unrounded values.

Disbursements reported for the country. The OECD record and the United States self-reported record are drawn separately. The two records cover the same United States disbursements, but the OECD record is filed by calendar year and the self-reported record by United States fiscal year.

People living with HIV and people on treatment

UNAIDS AIDSinfo

People living with HIV
People on treatment

Year	People living with HIV	People living with HIV (lower)	People living with HIV (upper)	People on treatment
2000	3,500	3,000	4,100	—
2001	3,900	3,300	4,400	—
2002	4,200	3,600	4,700	—
2003	4,400	3,900	5,000	—
2004	4,700	4,100	5,300	—
2005	4,800	4,300	5,400	—
2006	5,000	4,500	5,600	—
2007	5,200	4,600	5,800	—
2008	5,300	4,800	5,900	—
2009	5,500	5,000	6,100	—
2010	5,700	5,100	6,300	1,100
2011	5,800	5,300	6,500	1,300
2012	6,000	5,400	6,700	1,700
2013	6,200	5,600	6,900	1,900
2014	6,300	5,800	7,000	2,200
2015	6,500	5,900	7,200	2,300
2016	6,600	6,000	7,400	2,600
2017	6,800	6,100	7,600	2,700
2018	6,900	6,200	7,800	2,900
2019	7,100	6,400	7,900	2,900
2020	7,300	6,600	8,100	3,400
2021	7,400	6,700	8,300	3,300
2022	7,600	6,800	8,400	3,100
2023	7,700	6,900	8,600	3,800
2024	7,900	7,000	8,800	3,900

25 rows, as drawn above. Values are rounded for display, and the download gives the unrounded values.

Modelled estimates. The shaded area is the published uncertainty interval around the number of people living with HIV, because a single estimate without the interval would overstate the precision of the model.

The treatment cascade

UNAIDS AIDSinfo

Diagnosed
On treatment
Virally suppressed

Year	Diagnosed	On treatment	Virally suppressed
2010	—	20.0%	—
2011	—	22.0%	—
2012	—	28.0%	—
2013	49.0%	31.0%	21.0%
2014	51.0%	34.0%	26.0%
2015	50.0%	36.0%	29.0%
2016	51.0%	39.0%	30.0%
2017	52.0%	40.0%	34.0%
2018	50.0%	41.0%	36.0%
2019	49.0%	40.0%	37.0%
2020	55.0%	47.0%	41.0%
2021	52.0%	45.0%	38.0%
2022	48.0%	41.0%	36.0%
2023	51.0%	49.0%	43.0%
2024	53.0%	49.0%	45.0%

15 rows, as drawn above. Values are rounded for display, and the download gives the unrounded values.

Every line is a percentage of all people living with HIV, so the three lines share a denominator and can be compared directly. Viral suppression in the figure is the share of all people living with HIV who are virally suppressed, and not the narrower third 95 target, which counts only people on treatment.

Sources of the figures for Suriname

2,791 rows

Source	Type	Rows	Indicators	Years	Read from	Retrieved
UNICEF HIV/AIDS dataset	Modelled estimate	1,375	5	2010–2025	sdmx.data.unicef.org	2026-10-20
UNAIDS AIDSinfo	Modelled estimate	756	24	2000–2024	aidsinfo.unaids.org	2026-10-20
WHO Global Health Observatory	Modelled estimate	244	10	2000–2025	ghoapi.azureedge.net	2026-10-12
WHO Global Tuberculosis Programme	Programme record	155	16	2000–2024	extranet.who.int	2026-10-16
Global Fund Data Service	Programme record	61	8	2017–2025	fetch.theglobalfund.org	2026-10-12
World Bank Open Data	Modelled estimate	51	2	2000–2025	api.worldbank.org	2026-10-12
OECD Creditor Reporting System	Expenditure account	41	3	2002–2024	sdmx.oecd.org	2026-10-12
IATI, through d-portal	Expenditure account	36	3	2005–2026	d-portal.org	2026-10-12
PAHO Core Indicators	Programme record	30	1	2012–2024	opendata.paho.org	2026-10-13
ForeignAssistance.gov	Expenditure account	8	2	2007–2012	foreignassistance.gov	2026-10-29
PEPFAR testing by modality	Programme record	8	4	2018–2019	data.pepfar.gov	2026-10-12
PEPFAR results by province	Programme record	8	2	2016	data.pepfar.gov	2026-10-12
WHO HIV testing services dashboard	Programme record	8	4	2019	eic-database-290813.ew.r.appspot.com	2026-10-14
PEPFAR Panorama Spotlight	Programme record	4	2	2018–2019	data.pepfar.gov	2026-10-12
Global Fund allocations	Expenditure account	3	1	2017–2023	fetch.theglobalfund.org	2026-10-12
PEPFAR results by funding agency	Programme record	2	1	2018–2019	data.pepfar.gov	2026-10-12
PAHO Interactive HIV Data Dashboard	Programme record	1	1	2025	paho.org	2026-10-14

Indicators held

56 of 150

Indicator	Domain	Unit	Rows	Years	Sources	Most recent value
Actual expenditure on collaborative TB/HIV activities	Financing	USD	5	2018–2022	WHO Global Tuberculosis Programme	$1k (2022)
Budget required for collaborative TB/HIV activities	Financing	USD	6	2018–2023	WHO Global Tuberculosis Programme	$5k (2023)
Domestic funding received by the national TB programme	Financing	USD	6	2017–2022	WHO Global Tuberculosis Programme	$263k (2022)
Expected Global Fund funding for the national TB programme	Financing	USD	6	2018–2023	WHO Global Tuberculosis Programme	$97k (2023)
Expected USAID funding for the national TB programme	Financing	USD	5	2018–2023	WHO Global Tuberculosis Programme	$0 (2023)
Expected domestic funding for the national TB programme	Financing	USD	6	2018–2023	WHO Global Tuberculosis Programme	$370k (2023)
Expected funding for collaborative TB/HIV activities	Financing	USD	6	2018–2023	WHO Global Tuberculosis Programme	$3k (2023)
External HIV financing (all donors, ODA)	Financing	USD	22	2002–2024	OECD Creditor Reporting System	$815k (2024)
External HIV financing from governments other than the United States (IATI)	Financing	USD	11	2010–2025	IATI, through d-portal	$0 (2025)
External HIV financing from multilateral bodies other than the Global Fund (IATI)	Financing	USD	5	2015–2025	IATI, through d-portal	$118k (2025)
External HIV financing from the United States (ODA)	Financing	USD	8	2007–2012	ForeignAssistance.gov, OECD Creditor Reporting System	$6k (2012)
Funding received for collaborative TB/HIV activities	Financing	USD	5	2018–2022	WHO Global Tuberculosis Programme	$1k (2022)
Global Fund HIV allocation for a whole three-year cycle, not an annual figure	Financing	USD per three-year allocation cycle	3	2017–2023	Global Fund allocations	2,371,250 (2023)
Global Fund HIV disbursements to the country	Financing	USD	35	2005–2026	IATI, through d-portal, OECD Creditor Reporting System	$301k (2026)
Global Fund funding received by the national TB programme	Financing	USD	6	2017–2022	WHO Global Tuberculosis Programme	$144k (2022)
US HIV disbursements managed by other US agencies	Financing	USD	4	2007–2012	ForeignAssistance.gov	$18k (2012)
USAID funding received by the national TB programme	Financing	USD	6	2017–2022	WHO Global Tuberculosis Programme	$0 (2022)
% of ALL PLHIV who are virally suppressed	Treatment cascade	percent	23	2013–2025	UNAIDS AIDSinfo, WHO Global Health Observatory	46.0% (2025)
% of PLHIV on ART (second 95, PLHIV base)	Treatment cascade	percent	66	2000–2025	UNAIDS AIDSinfo, WHO Global Health Observatory	50.0% (2025)
% of PLHIV who have been diagnosed (first 95)	Treatment cascade	percent	25	2013–2025	UNAIDS AIDSinfo, WHO Global Health Observatory	56.0% (2025)
% of estimated HIV-positive incident TB cases on TB treatment and ART	Treatment cascade	percent	20	2003–2024	UNAIDS AIDSinfo	45.3% (2024)
% of people newly enrolled in HIV treatment diagnosed with TB disease	Treatment cascade	percent	3	2017–2019	UNAIDS AIDSinfo	1.7% (2019)
% of people on ART who are virally suppressed (third 95)	Treatment cascade	percent	11	2015–2025	WHO Global Health Observatory	92.0% (2025)
% of returned HIV test results that were positive	Treatment cascade	percent	4	2019	UNAIDS AIDSinfo, WHO HIV testing services dashboard	1.7% (2019)
HIV tests performed at a health facility	Treatment cascade	count	1	2019	WHO HIV testing services dashboard	33,661 (2019)
HIV tests performed through community outreach	Treatment cascade	count	3	2018–2019	PEPFAR testing by modality, WHO HIV testing services dashboard	3,702 (2019)
HIV tests performed with the result returned to the person	Treatment cascade	count	19	2016–2024	Global Fund Data Service, PEPFAR Panorama Spotlight, PEPFAR results by province, PEPFAR testing by modality, UNAIDS AIDSinfo, WHO HIV testing services dashboard	2,605 (2024)
HIV-exposed infants tested within two months of birth	Treatment cascade	percent	4	2010–2019	UNAIDS AIDSinfo	34.0% (2019)
HIV-positive TB patients started or continued on ART	Treatment cascade	count	20	2015–2024	Global Fund Data Service, WHO Global Tuberculosis Programme	18 (2024)
Key-population people tested for HIV (count over the period)	Treatment cascade	count	17	2019–2024	Global Fund Data Service	By population group, sex or age only, to 2024
New HIV diagnoses with a CD4 count below 200	Treatment cascade	percent	5	2015–2019	UNAIDS AIDSinfo	30.0% (2019)
Newly diagnosed at USAID-funded partners (MER HTS_TST_POS)	Treatment cascade	count	2	2018–2019	PEPFAR results by funding agency	37 (2019)
Notified HIV cases, national case surveillance	Treatment cascade	count	31	2012–2025	PAHO Core Indicators, PAHO Interactive HIV Data Dashboard	660 (2025)
Number newly diagnosed HIV-positive (PEPFAR MER HTS_TST_POS)	Treatment cascade	count	7	2016–2019	PEPFAR Panorama Spotlight, PEPFAR results by province, PEPFAR testing by modality	37 (2019)
Number of people on ART (PEPFAR MER TX_CURR)	Treatment cascade	count	73	2000–2025	Global Fund Data Service, UNAIDS AIDSinfo, WHO Global Health Observatory	4,070 (2025)
PMTCT ART coverage among pregnant women with HIV	Treatment cascade	percent	30	2010–2024	UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset	63.0% (2024)
People newly diagnosed through community outreach	Treatment cascade	count	2	2018–2019	PEPFAR testing by modality	37 (2019)
People newly enrolled on ART during the year	Treatment cascade	count	6	2017–2024	Global Fund Data Service, WHO Global Tuberculosis Programme	447 (2024)
Pregnant women with HIV who received ARVs for PMTCT	Treatment cascade	count	30	2010–2024	UNAIDS AIDSinfo, WHO Global Health Observatory	95 (2024)
TB patients recorded as HIV-positive	Treatment cascade	count	15	2015–2024	WHO Global Tuberculosis Programme	22 (2024)
TB patients with an HIV test result recorded	Treatment cascade	count	18	2015–2024	Global Fund Data Service, WHO Global Tuberculosis Programme	119 (2024)
AIDS-related deaths	Epidemic estimates	count	681	2000–2025	UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset, WHO Global Health Observatory	500 (2025)
Deaths from TB among people living with HIV	Epidemic estimates	count	50	2000–2024	UNAIDS AIDSinfo, WHO Global Tuberculosis Programme	14 (2024)
HIV prevalence among a key population	Epidemic estimates	percent	2	2024	UNAIDS AIDSinfo	By population group, sex or age only, to 2024
HIV prevalence, ages 15-49	Epidemic estimates	percent	50	2000–2024	UNAIDS AIDSinfo, World Bank Open Data	1.6% (2024)
Incident TB cases among people living with HIV	Epidemic estimates	count	50	2000–2024	UNAIDS AIDSinfo, WHO Global Tuberculosis Programme	40 (2024)
New HIV infections	Epidemic estimates	count	585	2000–2025	UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset, WHO Global Health Observatory	500 (2025)
People living with HIV	Epidemic estimates	count	681	2000–2025	UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset, WHO Global Health Observatory	8,100 (2025)
Key-population members reached by prevention programmes	Prevention and outreach	percent	1	2024	UNAIDS AIDSinfo	By population group, sex or age only, to 2024
Key-population people reached by outreach (count over the period)	Prevention and outreach	count	17	2019–2024	Global Fund Data Service	By population group, sex or age only, to 2024
Male condoms distributed in a year	Prevention and outreach	count	1	2019	UNAIDS AIDSinfo	437,964 (2019)
People receiving PrEP	Prevention and outreach	count	3	2024–2025	Global Fund Data Service	74 (2025)
Estimated pregnant women with HIV needing ARVs for PMTCT	Population denominators	count	31	2010–2025	UNAIDS AIDSinfo, WHO Global Health Observatory	200 (2025)
Estimated size of a key population	Population denominators	count	2	2024	UNAIDS AIDSinfo	By population group, sex or age only, to 2024
Total population	Population denominators	count	26	2000–2025	World Bank Open Data	639,850 (2025)
Share of HIV-exposed infants who acquire HIV	—	percent	31	2010–2025	UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset	10.9% (2025)

Every row shown on the Suriname page is in the panel download, with the source URL and the retrieval date of the row attached. See Data.